Femasys announces the expansion of its commercial management team, marking a significant milestone in the company’s mission to advance women’s health worldwide. With the addition of new team members to its commercial team in key strategic geographical locations, Femasys is poised to fully initiate its strategic initiatives and execute on its delivery of innovative, accessible options to impact women’s healthcare.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY:
- Femasys Releases Updated Investor Presentation Information
- Femasys CEO meets with members of Congress to raise awareness
- Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives
- Femasys price target raised to $12 from $10 at H.C. Wainwright
- Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update